---
title: "Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 ... — FDA record D-0641-2024 | Is It on Recall"
description: "Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information."
url: https://isitonrecall.com/recall/fda-drug-d-0641-2024-healthy-living-acetaminophen-aspirin-nsaid-and-caffeine-tablets-usp-250-mg-250-mg-65-mg-100-count-bo/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Dist... — FDA record D-0641-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jul 11, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by: Aurohealth LLC, 279 Princeton-Hightstown Road, East Windsor, NJ , Made in India, NDC 58602-882-21.
- **Reason**: Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
- **Classification**: Class I
- **Recalling firm**: Aurobindo Pharma USA Inc
- **Quantity**: 240 bottles
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0641-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0641-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot#: AC2523005A, Exp 6/30/2025 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

NJ, NY & PA

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [New York](https://isitonrecall.com/state/new-york/)
- [Pennsylvania](https://isitonrecall.com/state/pennsylvania/)

## Dates in the source

- **Report date**: Aug 28, 2024
- **Recall initiation date**: Jul 11, 2024
- **Center classification date**: Aug 20, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0641-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Acetaminophen records](https://isitonrecall.com/drug/acetaminophen/) [Medications records](https://isitonrecall.com/category/medications/) [Aurobindo Pharma USA Inc. records](https://isitonrecall.com/brand/aurobindo-pharma-usa-inc/)